Alabama: Ownership and Oversight
Restricted: dual-board collaboration with physician-presence percentages. Alabama runs one of the most physician-intensive collaboration systems in the country — protocols filed with two boards, mandatory physician presence percentages for new CRNPs, quarterly quality assurance, a 360-hour weekly cap on each physician's advanced practice coverage, and a two-permit system for controlled substances.
Who the Statute Actually Covers
- The collaborative practice agreement (Ala. Code § 34-21-80 et seq.; Ala. Admin. Code 540-X-8, 610-X-5): a written standard protocol specific to both parties' specialties, signed by both, maintained at every practice site, and on file with both the Board of Nursing and the Board of Medical Examiners. Identifies all practice sites, the physician's principal site, a formulary, an emergency plan, a referral process, and a QA plan; commencement and termination reported to the Medical Board (termination within 14 days). Physician eligibility: 3 years of practice, or 1 year plus board certification, or 1 year with a hospital-limited site.
- Physician presence and meetings (610-X-5-.09): for a CRNP with under 2 years (4,000 hours) of collaborative experience, the physician must be present for at least 10% of the CRNP's scheduled hours at an approved site. For experienced CRNPs, quarterly meetings plus remote-site visits at least twice annually. Quarterly quality assurance always, documented and retained 3 years past termination. Pre-approved covering physicians may substitute. Home, ADPH, and mental-health facility hours are exempt from the presence minimums.
- The 360-hour cap (540-X-8-.12): a physician may not collaborate with or supervise CRNPs, CNMs, and PAs exceeding 360 FTE-hours per week (nine full-time equivalents) combined. Health departments exempt; 45-day transitional allowances available.
- Controlled substances: a QACSC (annual, specific to each collaborative agreement) for Schedules III–V, requiring 12 months of active Alabama practice, an 8-hour controlled-substance course plus 4 hours of advanced pharmacology within the prior year, then DEA registration. Schedule II requires the separate Limited Purpose Schedule II Permit (LPSP), with 90-day continuation decisions made with the physician. Obesity/weight-loss prescribing is separately restricted (540-X-17) — directly relevant to GLP-1 models.
1. Who Can Own What
| Entity / Path | Who May Own | Key Limits |
|---|---|---|
| Professional entities | Licensee-owned professional corporations/LLCs under Alabama entity statutes; corporate practice policed through the Medical Board. | Verify combinations with Alabama counsel. |
| CRNP-owned practice | Legally possible but operationally physician-heavy: the owner needs a collaborator with capacity under the 360-hour cap, presence percentages if newly practicing, and dual-board protocol filings. | Hospital practice requires both the CRNP and collaborating physician to hold privileges at that hospital. |
| PA path | Registration-based physician supervision under the Medical Board; PAs count against the same 360-hour combined cap. | — |
| Lay / MSO | Standard exclusion; the state polices through protocol approval and the Medical Board. | Monitor: 2025–26 industry reporting indicates Alabama enacted expanded practice pathways — verify current status. |
2. Collaborative and Supervisory Oversight
| Role | Agreement Required | Oversight Mechanics | Path to Independence |
|---|---|---|---|
| PA | Board-registered physician supervision; counted within the physician's 360 FTE-hour weekly cap; mechanics per Medical Board rules. | Verify current supervision agreement content with the ABME. | None. |
| NP / CRNP | Dual-board-filed standard protocol with formulary, QA plan, emergency and referral provisions; physician readily available at all times with pre-approved covering physicians. | Under 4,000 hours: physician present 10% of scheduled hours. Over: quarterly meetings + twice-annual remote site visits. Quarterly QA always. 360 FTE-hour/9-FTE combined cap per physician. QACSC (Sch III–V, annual, per-agreement) and LPSP (Sch II) for controlled substances; obesity prescribing restricted; CRNPs cannot activate advance directives. | None under the framework described; monitor 2025–26 legislative developments. |
3. Primary Authorities
- Ala. Code § 34-21-80 et seq.; Ala. Admin. Code 610-X-5-.09 and 540-X-8 (protocols; presence percentages; QA; covering physicians; 14-day termination notice).
- Ala. Admin. Code 540-X-8-.12 (360 FTE-hour cap); 540-X-17 (obesity prescribing); ABME QACSC and LPSP rules (540-X-12, 540-X-18).
Practical read: Alabama is the state where collaboration is a genuine operating cost, not a signature. 10% physician presence for new CRNPs is scheduled clinic time; the QACSC's 12-month Alabama practice prerequisite delays controlled-substance capability for relocating NPs by a full year; the per-agreement QACSC means every collaboration change re-opens the certificate. For weight-loss and GLP-1 clients, read 540-X-17 before anything else.
General education, not legal advice. Verify current statutes, board rules, and opinions before relying on this summary.